ASLAN Pharmaceuticals Ltd
DelistedCIK 1722926fmd_1JSASCTAQPT8JADCNXQKDS3551Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Dec 31, 2023, 16 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 12 | – | – | 3 | – | 0 | 0 | 12 |
| Cost of revenue | 0 | – | – | 0 | – | – | – | – |
| Gross profit | 11 | – | – | 3 | – | – | – | 12 |
| Research and development | 13 | 30 | 32 | 17 | 9 | 22 | 38 | 42 |
| Operating income | (9) | (39) | (42) | (46) | (16) | (34) | (48) | (44) |
| Interest expense | 1 | 0 | 0 | 1 | 1 | 2 | 4 | 4 |
| Income before taxes | (9) | (40) | (42) | (47) | (17) | (32) | (51) | (44) |
| Income tax expense | – | – | 0 | 0 | 0 | – | 0 | 0 |
| Net income from continuing operations | – | – | (42) | (47) | (17) | – | (51) | (44) |
| Net income | (9) | (40) | (42) | (47) | (16) | (31) | (51) | (44) |